USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: CATABASIS PHARMACEUTICALS, INC.
City: CAMBRIDGE
State: MA
Zip+4: 02139
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $179,900.00 1

Award List:

CAT1920: A Small Molecule Therapeutic for the Treatment of IBD

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael R. Jirousek
Award Amount: $179,900.00
Abstract:
DESCRIPTION (provided by applicant): 5-Aminosalicylic acid (5-ASA) and its analogs such as the prodrug sulfasalazine are front line therapy for Inflammatory Bowel Disease (IBD), which include both Crohn's disease and ulcerative colitis. 5-ASA is only moder ately efficacious in putting patients into… More